Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
StockPreacher.com Issues Trading Outlook for Nabi Biopharmaceuticals
Nabi Biopharmaceuticals Announces Sale of PentaStaph(tm) to GlaxoSmithKline PLC
Nabi Biopharmaceuticals to Announce 2009 Second Quarter Financial Results on August 6, 2009
Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference
Nabi Biopharmaceuticals Receives Scientific Advice On NicVAX(r) From the European Medicines Agency
Nabi Biopharmaceuticals to Present At Noble Financial's Fifth Annual Equity Conference
Nabi Biopharmaceuticals Announces Withdrawal of Biotest's Indemnification Claim
Nabi Biopharmaceuticals Announces First Quarter 2009 Financial Results
Nabi Biopharmaceuticals to Announce 2009 First Quarter Financial Results On May 6, 2009
Nabi Biopharmaceuticals Announces Date for 2009 Annual Meeting of Shareholders
Nabi Biopharmaceuticals Announces Fourth Quarter and Full-Year 2008 Financial Results
Nabi Biopharmaceuticals to Present At the Noble Financial Capital Markets Boston Uncommon Conference
Nabi Biopharmaceuticals to Announce 2008 Fourth Quarter and Year-End Financial Results On March 11, 2009
Nabi Biopharmaceuticals Reaches Special Protocol Agreement With FDA for NicVAX(r) Phase 3 Trial Protocol
Nabi Biopharmaceuticals Enters Clinical Initiative With US Military to Advance PentaStaph(tm)
Nabi Biopharmaceuticals Significantly Enhances Gram-Positive Patent Portfolio
Nabi Biopharmaceuticals Announces Third Quarter 2008 Financial Results
Nabi Biopharmaceuticals Announces Successful Final Results of NicVAX(r) Immunogenicity Study
Nabi Biopharmaceuticals to Announce Third Quarter Financial Results On November 6, 2008
DellaCamera Sends Letter to Nabi Biopharmaceuticals Board of Directors
Nabi Biopharmaceuticals and NIAID to Advance PentaStaph Vaccine Research
Nabi Biopharmaceuticals Announces Second Quarter 2008 Financial Results
Nabi Biopharmaceuticals Announces Arbitration Settlement With Inhibitex, Inc.
Nabi Biopharmaceuticals to Announce Second Quarter Financial Results On August 7, 2008
Nabi Biopharmaceuticals Announces Positive Interim Results of NicVAX Immunogenicity Study
Nabi Biopharmaceuticals Announces Receipt of $2.5 Million Milestone Payment
Nabi Biopharmaceuticals Announces First Quarter 2008 Financial Results
Nabi Biopharmaceuticals to Announce First Quarter Financial Results On May 8, 2008
Nabi Biopharmaceuticals Prevails in Opposition Hearing for NicVAX Patent
Nabi Biopharmaceuticals Announces Settlement of Litigation
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
